Teladoc Health, Inc. (NYSE:TDOC) Receives $12.08 Consensus PT from Analysts

Teladoc Health, Inc. (NYSE:TDOCGet Free Report) has been assigned an average recommendation of “Hold” from the twenty-one brokerages that are presently covering the firm, MarketBeat.com reports. Fourteen investment analysts have rated the stock with a hold recommendation and seven have given a buy recommendation to the company. The average 12 month price objective among analysts that have updated their coverage on the stock in the last year is $12.08.

A number of research analysts have commented on TDOC shares. Royal Bank of Canada upped their target price on shares of Teladoc Health from $11.00 to $12.00 and gave the company an “outperform” rating in a research report on Friday, January 24th. Deutsche Bank Aktiengesellschaft increased their price target on shares of Teladoc Health from $10.00 to $12.00 and gave the stock a “hold” rating in a research report on Friday, November 1st. TD Cowen reduced their price target on shares of Teladoc Health from $9.00 to $8.00 and set a “hold” rating on the stock in a research report on Thursday, October 31st. The Goldman Sachs Group initiated coverage on shares of Teladoc Health in a research report on Friday, November 15th. They set a “buy” rating and a $14.00 price target on the stock. Finally, Oppenheimer reduced their price target on shares of Teladoc Health from $14.00 to $12.00 and set an “outperform” rating on the stock in a research report on Friday, January 24th.

Check Out Our Latest Stock Analysis on Teladoc Health

Insider Buying and Selling at Teladoc Health

In other Teladoc Health news, insider Carlos Nueno sold 2,389 shares of the stock in a transaction that occurred on Monday, December 2nd. The shares were sold at an average price of $11.93, for a total value of $28,500.77. Following the transaction, the insider now directly owns 2,890 shares in the company, valued at $34,477.70. This represents a 45.25 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. 0.95% of the stock is currently owned by insiders.

Hedge Funds Weigh In On Teladoc Health

A number of hedge funds have recently modified their holdings of TDOC. American Century Companies Inc. grew its position in shares of Teladoc Health by 31.0% during the second quarter. American Century Companies Inc. now owns 136,351 shares of the health services provider’s stock worth $1,334,000 after acquiring an additional 32,240 shares during the last quarter. Vanguard Personalized Indexing Management LLC purchased a new position in Teladoc Health in the 2nd quarter valued at $133,000. Benjamin F. Edwards & Company Inc. grew its position in Teladoc Health by 209.8% in the 2nd quarter. Benjamin F. Edwards & Company Inc. now owns 5,015 shares of the health services provider’s stock valued at $49,000 after buying an additional 3,396 shares during the last quarter. Bank of Montreal Can grew its position in Teladoc Health by 470.6% in the 2nd quarter. Bank of Montreal Can now owns 94,466 shares of the health services provider’s stock valued at $926,000 after buying an additional 77,909 shares during the last quarter. Finally, Xponance Inc. purchased a new position in Teladoc Health in the 2nd quarter valued at $105,000. 76.82% of the stock is currently owned by hedge funds and other institutional investors.

Teladoc Health Trading Down 1.8 %

NYSE TDOC opened at $10.16 on Monday. The firm’s 50-day moving average is $10.08 and its two-hundred day moving average is $9.07. Teladoc Health has a 12 month low of $6.76 and a 12 month high of $21.74. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.73 and a quick ratio of 1.69. The stock has a market capitalization of $1.75 billion, a P/E ratio of -1.76 and a beta of 1.01.

About Teladoc Health

(Get Free Report

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.

Featured Articles

Analyst Recommendations for Teladoc Health (NYSE:TDOC)

Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter.